Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03JRO
|
||||
| Former ID |
DIB008870
|
||||
| Drug Name |
ADCI
|
||||
| Synonyms |
SBG-017
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Epileptic seizures [ICD9: 345.9, 780.3; ICD10:G40, P90, R56] | Phase 1 | [525718] | ||
| Company |
National Institutes of Health
|
||||
| Formula |
C16H14N2O
|
||||
| Canonical SMILES |
C12(NC(c3c1cccc3)Cc1c2cccc1)C(=O)N
|
||||
| CAS Number |
CAS 124070-15-1
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Modulator | [525718] | |
| Sodium channel | Target Info | Modulator | [525718] | ||
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.